MAHAFFY PATRICK J — SEC insider filings
SEC reporting owner CIK 1266569. 8 insider filings on record with FilingPulse; latest filed 2026-11-17.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2021-03-03 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Flexion Therapeutics Inc (FLXN) | Director | 2 | — | — | 11 |
| Clovis Oncology, Inc. (CLVS) | See Remarks, Director | 2 | — | — | 7 |
| Medicus Pharma Ltd. (MDCX) | Director | 4 | — | — | 4 |
Insider filings — MAHAFFY PATRICK J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-17 | 4 | Medicus Pharma Ltd. (MDCX) | Grant/award (A): 14,534 @ $1.72 | EDGAR |
| 2026-06-04 | 4 | Medicus Pharma Ltd. (MDCX) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | Medicus Pharma Ltd. (MDCX) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-12-18 | 4 | Medicus Pharma Ltd. (MDCX) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2022-03-03 | 4 | Clovis Oncology, Inc. (CLVS) | Grant/award (A): 220,000 (derivative) @ $0 · Grant/award (A): 80,000 (derivative) @ $0 · Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2021-11-19 | 4 | Flexion Therapeutics Inc (FLXN) | Disposition to issuer (D): 39,824 @ $8.50 · Disposition to issuer (D): 18,000 (derivative) · Disposition to issuer (D): 18,000 (derivative) · Disposition to issuer (D): 18,000 (derivative) · Disposition to issuer (D): 18,000 (derivative) · Disposition to issuer (D): 18,000 (derivative) · +3 more | EDGAR |
| 2021-06-28 | 4 | Flexion Therapeutics Inc (FLXN) | Grant/award (A): 4,500 @ $0 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2021-03-03 | 4 | Clovis Oncology, Inc. (CLVS) | Grant/award (A): 220,000 (derivative) @ $0 · Grant/award (A): 80,000 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1266569 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs